GlassScriptPhysician profile
William Chalmers Ruffin
NPI 1023578804
$1,554.42
in general payments reported to CMS, 2019-2025
14 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.99 · 2023: $184 · 2024: $771 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.45 |
| Travel and Lodging | $412.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $731.35 | 2024-2025 | Inspire |
| Stryker Corporation | $164.53 | 2023 | Audion Et Dilation System |
| Genzyme Corporation | $137.17 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $126.27 | 2024-2025 | Dupixent, Libtayo |
| Medtronic, INC. | $89.79 | 2022-2025 | Straightshot, Fusion, Novapak |
| Advanced Bionics, LLC | $85.62 | 2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Glaxosmithkline, LLC. | $53.31 | 2025 | Nucala |
| Med-El Corporation | $35.54 | 2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Cochlear Americas | $33.27 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Integra Lifesciences Corporation | $24.19 | 2024 | Instruments-Orthopedic, Integra Duo, Microfrance |
| Neurent Medical Limited | $23.85 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Ars Pharmaceuticals Operations, INC. | $23.24 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $15.25 | 2025 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $11.04 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ruffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.